Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading update

28 Mar 2024 07:00

RNS Number : 5857I
IDOX PLC
28 March 2024
Β 

28 March 2024

Idox plc

('Idox'Β orΒ theΒ 'Group'Β orΒ theΒ 'Company')

AGM Trading update

Good momentum continues in the current financial year

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, is pleased to issue a trading update for the period from 1 November 2023 to date, ahead of today's Annual General Meeting.

Highlights during the period include:

Β· Operational and financial performance continue to be in line with the Board's expectations and we remain confident about the outlook for the year.

Β· High levels of recurring revenue, contract renewals, orderbook and pipeline provide good visibility, leaving Idox well placed to grow by double digits in FY24.

Β· With a strong foundation in property and asset-based solutions and data services we continue to enhance and grow our capabilities across the Group.

Β· The integration of Emapsite (acquired August 2023) is progressing well and in line with our expectations.

Β· Idox has an attractive M&A pipeline with significant financial resources for larger, accretive and enhancing acquisitions at appropriate valuations.

A further trading update will be issued following the half year ending 30 April 2024.

David Meaden, Chief Executive Officer, said:

"We remain confident that Idox is well positioned for growth in FY24 and beyond. The Group has made a good start to the year and continues to trade in line with the Board's expectations. Our focus on securing high quality recurring revenue and repeatable services provides confidence in delivering double digit growth in FY24. We have a healthy balance sheet and are confident we can maximise the opportunities for profitable organic and inorganic growth whilst remaining resilient to the current macro-economic challenges."

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

Β 

Anoop Kang, Chief Financial Officer

Β 

Β 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Β 

Adam Telling

Β 

Β 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

Β idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

Β 

About Idox plc

For more information seeΒ www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRGDXRDDDGSR
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.